000 | 01953 a2200601 4500 | ||
---|---|---|---|
005 | 20250517042140.0 | ||
264 | 0 | _c20160315 | |
008 | 201603s 0 0 eng d | ||
022 | _a2219-2840 | ||
024 | 7 |
_a10.3748/wjg.v21.i25.7869 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXu, Yan | |
245 | 0 | 0 |
_aLong-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. _h[electronic resource] |
260 |
_bWorld journal of gastroenterology _cJul 2015 |
||
300 |
_a7869-76 p. _bdigital |
||
500 | _aPublication Type: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
650 | 0 | 4 |
_aAsian People _xgenetics |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 |
_aChina _xepidemiology |
650 | 0 | 4 |
_aDNA, Viral _xblood |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aGuanine _xadverse effects |
650 | 0 | 4 |
_aHepatitis B _xcomplications |
650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferons |
650 | 0 | 4 |
_aInterleukins _xgenetics |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Cirrhosis _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aZhang, Yong-Gui | |
700 | 1 | _aWang, Xu | |
700 | 1 | _aQi, Wen-Qian | |
700 | 1 | _aQin, Shao-You | |
700 | 1 | _aLiu, Zhen-Hua | |
700 | 1 | _aJiao, Jian | |
700 | 1 | _aWang, Jiang-Bin | |
773 | 0 |
_tWorld journal of gastroenterology _gvol. 21 _gno. 25 _gp. 7869-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v21.i25.7869 _zAvailable from publisher's website |
999 |
_c25066934 _d25066934 |